Liver inflammation and fibrosis
Воспаление и фиброз печени
2017-01-02
SCID: 54.1/sc5ufghq
Discuss with AI
Kupffer cellshepatic fibrosishepatic steatosishepatic stellate cellsliver inflammation
Figures from the paper
Abstract (AI)
Chronic liver inflammation leads to fibrosis and cirrhosis, which is the 12th leading cause of death in the United States. Hepatocyte steatosis is a component of metabolic syndrome and insulin resistance. Hepatic steatosis may be benign or progress to hepatocyte injury and the initiation of inflammation, which activates immune cells. While Kupffer cells are the resident macrophage in the liver, inflammatory cells such as infiltrating macrophages, T lymphocytes, neutrophils, and DCs all contribute to liver inflammation. The inflammatory cells activate hepatic stellate cells, which are the major source of myofibroblasts in the liver. Here we review the initiation of inflammation in the liver, the liver inflammatory cells, and their crosstalk with myofibroblasts.
Key Findings
1
Chronic liver inflammation drives fibrosis and cirrhosis, a major cause of mortality in the United States.
2
Crosstalk between inflammatory cells and myofibroblasts contributes to the development of liver fibrosis.
3
Hepatocyte steatosis associated with metabolic syndrome and insulin resistance can remain benign or progress to injury and inflammatory activation.
4
Inflammatory cells activate hepatic stellate cells, which are the principal source of liver myofibroblasts.
5
Liver inflammation involves resident Kupffer cells and infiltrating macrophages, T lymphocytes, neutrophils, and dendritic cells.
Research Object
liver inflammation and fibrosis
Research Subject
the initiation of liver inflammation, the roles and interactions of hepatic inflammatory cells, and their crosstalk with myofibroblasts
Publication Details
Publication Date
2017-01-02
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest